Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder
Rajiv Tandon(Western Michigan University), Pascal Van Peborgh(Bristol-Myers Squibb (United Kingdom)), Bruno Falissard(Inserm), William H. Carson(University of Chicago), D. Jody, Patricia K. Corey‐Lisle(Eli Lilly (United States)), Serdar Dursun(University of Alberta), Hong Li(Second Affiliated Hospital of Zhejiang University), Robert D. McQuade, Jian Han(Bristol-Myers Squibb (United States)), Gilbert L’Italien(Bristol-Myers Squibb (United States)), Saurabh Ray(New York University Abu Dhabi), J.N. Beuzen(Bristol-Myers Squibb (Belgium)), Mary J. Kujawa(Bristol-Myers Squibb (United States)), Ronald N. Marcus(Bristol-Myers Squibb (United States)), Robert F. DeVellis(University of North Carolina at Chapel Hill), Sophia Frangou(University of British Columbia)
Cited by 40
Related Papers
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
|Journal of Clinical Epidemiology|2010|5.1k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial
|The Lancet|2011|674
Complicated grief after death of a relative in the intensive care unit
|European Respiratory Journal|2015|359